progress has been made in the validation and application of In 1982 we proposed the concept and a framework for biomarkers (2-7). Perhaps the greatest contribution of molecuimplementing molecular cancer epidemiology. Here, we lar epidemiology has been the insights it has provided into review progress during the past 17 years in validating and interindividual variation in human cancer risk and the complex applying this approach to cancer prevention. There have interactions between environmental factors and host susceptibeen major advances, notably in the understanding of bility factors, both inherited and acquired, in the multistage environment-susceptibility interactions in human cancer.
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process of carcinogenesis (8).
However, a review of major findings to date reveals several
Molecular epidemiology has as its ultimate goal the prevenurgent research needs to keep pace with the rapid evolution tion of cancer, a disease that in the USA claims over 500 000 in knowledge of mechanisms in carcinogenesis. Although lives annually, with more than 1 000 000 new cases diagnosed much valuable progress continues to be made in the study each year (9). Even more clearly than in 1982, various lines of carcinogens that cause direct DNA damage and are of evidence indicate that the great majority of cancer is, in mutagenic, exogenous and endogenous carcinogens can also principle, preventable because the factors that determine cancer act by altering gene expression, cell proliferation and incidence are largely exogenous (10). This evidence comes differentiation. The mechanisms include aberrant DNA mainly from epidemiologic studies and includes: (i) time trends methylation, oxidative damage, effects on metabolism of in cancer incidence and mortality; (ii) geographic variations nitrogen oxide and nitrites, activation of receptors and and the effects of migration; (iii) the identification of specific transcription factors, cyclins and other cell cycle proteins.
causative factors such as cigarette smoking, occupational and Sensitive, validated biomarkers are needed to detect these environmental chemicals, radiation, dietary factors and viruses; mechanisms in small numbers of cells, tissues or fluids.
and (iv) the observation that the majority of human cancers There is also increasing recognition that individual risk do not show simple patterns of inheritance. Genetic factors from carcinogen exposure varies as a function of both are clearly important in terms of influencing individual suscepinherited and acquired factors. Recent advances in genomtibility to carcinogens; and in certain rare forms of human ics, microassay technologies and informatics hold promise cancer, hereditary factors play a decisive role. However, for rapid identification of polymorphic variants or changes external factors represent the greatest opportunity for primary in expression of genes influencing both response and suscepprevention. This is an optimistic message because it means tibility to carcinogens. Another emerging area of molecular that the development of cancer is not an inherent consequence epidemiology concerns the role of nutrition and specific of the aging process per se, and the human species is not dietary factors (including studies on antioxidants, energy inevitably destined to suffer a high incidence of cancer. This metabolism, insulin and various growth factors) and the awareness has lent greater urgency to the search for more modulating effect of genetic polymorphisms. Finally, powerful tools for primary prevention-for early warning sysmolecular epidemiology has enormous potential in cancer tems to identify causal environmental agents and flag risks prevention through the early identification of 'at risk ' well before the malignant process is entrenched. populations and the rapid assessment of intervention efficacy. Its success in fully reaching this potential will depend Overview of recent progress in molecular epidemiology on the application of validated biomarkers, with adherence to sound epidemiologic and ethical principles.
Until recently, the majority of cancer epidemiology studies were limited to assessing possible causative associations between two types of events: exposure to potential causative Introduction 'environmental' agents (i.e. cigarette smoke, specific chemicals in the workplace, dietary factors, etc.) and disease outcome In 1982, we proposed the concept and a framework for (i.e. clinically apparent cancer incidence or cancer mortality). implementing molecular cancer epidemiology-the merging
The modulation of environmental factors by host susceptibility of molecular biology and epidemiology in the study of cancer was rarely evaluated. However, within the past few years, the causation and, ultimately, in the prevention of this disease (1).
interaction between environmental factors and host susceptibilOur paper presented a conceptual framework for incorporating ity factors has become a very active area of research. Increasbiomarkers (biochemical or molecular alterations detectable in ingly, molecular epidemiologic studies are incorporating panels of biomarkers relevant to exposure, preclinical effects and tissues and body fluids (7,8). These biomarkers are now being a potential chemical carcinogen or its metabolites in a variety of cells, tissues or body fluids. Biomarkers of internal dose take widely used in cross-sectional, retrospective, prospective and nested case-control epidemiologic studies, with the aim of into account individual differences in absorption, metabolism, bioaccumulation or excretion of the compound in question and improving our understanding of the causes of specific human cancers.
indicate the actual level of the compound within the body and in specific tissues or compartments. However, their half-lives Although molecular epidemiology has the advantage of being directly relevant to human risk, unlike animal or other range from a few hours to decades, so their interpretation and applicability to different study designs vary accordingly (15). experimental models that require extrapolation to humans, it is also subject to many of the general limitations of epidemiologic Examples include cotinine in serum or urine, resulting from cigarette smoke exposure; urinary levels of 1-hydroxypyrene studies, such as vulnerability to confounding factors. In addition, many of the biomarkers used in molecular epidemiologic from exposure to polycyclic aromatic hydrocarbons (PAHs); aflatoxin B 1 (AFB 1 ) levels in urine, reflecting dietary sources; studies require further validation; as discussed in detail elsewhere (5,11). Furthermore, without adequate precautions the N-nitroso compounds or their metabolites in urine from dietary or endogenous sources; DDT, polychlorinated biphenyls use of these biomarkers carries the potential for serious social harm (reviewed in refs 12 and 13). At the present time, (PCBs), dioxins and furans in serum or adipose tissue biopsies, due to workplace and environmental contamination; infectious many biomarkers can be useful in assessing exposure, early deleterious molecular and biologic effects and potential risk agents in target tissues such as human papillomavirus (HPV); and mutagenicity of urine, a generic dosimeter of genotoxic for a group or population; most are not, however, sufficiently characterized or validated for routine use in screening, diagagents present in the body as a consequence of exposure to cigarette smoke or other environmental sources. nosis or quantitative estimation of individual risk of developing cancer.
Although markers of internal dose are a valuable supplement to conventional methods of assessing exposure, they do not As we proposed in 1982 (1), biomarkers have generally been classified into four major categories: (i) internal dose;
indicate the extent to which a given compound has interacted with critical cellular targets. Therefore, assays have been (ii) biologically effective dose; (iii) preclinical biologic effects; and (iv) susceptibility, with some overlap between them (14) developed to measure the 'biologically effective dose' of a compound, i.e. the amount that has reacted with critical cellular (Figure 1 The powerful PCR method and variations thereof have greatly facilitated the analysis of somatic mutations in molecuexperimental animals (19). Another limitation is that, because of DNA repair and tissue renewal, levels of carcinogen-DNA lar epidemiologic studies (37) . It is now possible to detect such mutations in tissues of exposed individuals at a very adducts generally reflect exposure during the previous several months, rather than exposure in the distant past (20).
early stage in the carcinogenic process; that is, even before cells carrying mutated genes have undergone clonal expansion. Since 1982, when the in vivo occurrence of carcinogen-DNA adducts was first reported in a human population (21), Characteristic patterns of mutations in tumors have provided valuable, albeit circumstantial, molecular evidence of the many different types of carcinogen-DNA adducts have been detected in human cells and tissues (17,18,22-24). [There was importance of specific environmental carcinogens. For example, because mutations of the p53 tumor suppressor gene one prior report of methylated purine in two samples of human liver as a result of intentional poisoning (25) .] Carcinogenand the ras oncogene are common events in human cancer, they can be useful reporters of carcinogenic events involved protein adducts, especially adducts formed with hemoglobin or albumin, have also been widely measured as surrogates for in the development of cancer. In a number of cases, the patterns of p53 and ras mutations in human tumors have been DNA damage (26, 27) . The use of longer-lived adducts with histone and collagen molecules is now being explored (26) .
consistent with the types of DNA adducts implicated in their causation and with the types of mutations induced The carcinogens whose derivatives have been found to covalently bind to DNA or protein include such diverse agents as experimentally by the specific environmental carcinogens under investigation (38, 39) . Thus, the mutation profile or spectrum ethylene oxide, 4-aminobiphenyl, PAH, AFB 1 , nitrosamines and cisplatin (17, 18, 22, (26) (27) (28) . Not surprisingly, in many found in certain genes may, in some instances, serve as a fingerprint of the causative agent. In recent studies, PCR-based different populations, the adduct data show a general doseresponse relationship for the genotoxic carcinogens studied, methods have demonstrated that histologically 'normal' areas of the bronchial epithelium of cigarette smokers can display with no apparent threshold. Adducts have gained relevance as a potential risk marker from the recent finding that patients specific chromosomal areas of LOH that are often found in lung cancers (40) . LOH can be considered a biomarker of with lung cancer had markedly higher PAH-DNA adduct levels in their peripheral white blood cells than individuals biologic effect that may be useful in identifying individuals who do not yet have cancer but are at high risk. without cancer, after taking into account differences in the amount of smoking and other potential confounders (17, 29) .
Other types of biomarkers may be indicative of the dose and effects of agents that enhance the carcinogenic process Other molecular epidemiologic studies have prospectively linked DNA damage from AFB 1 to liver cancer risk in Chinese without forming covalent adducts with cellular DNA or proteins, and without directly inducing gene mutations. These and Taiwanese populations (30-32). In virtually every study, the levels of DNA damage or protein adducts have been found agents appear to act by disrupting gene expression, cell growth, apoptosis and/or differentiation. They include certain tumor to vary considerably between persons with apparently similar exposure (20, 33, 34) . As has been shown with PAH-DNA promoters (12-O-tetradecanoylphorbol-13-acetate and phenobarbitol), xenobiotics (such as 2,3,7,8-terachlorodibenzo-padducts, although the observed variability reflects a combination of true biologic variability, unaccounted for differences dioxin, PCBs and various pesticides) and natural and synthetic estrogens and androgens. Assays for the biologic effects of in exposure, within-person variability, and laboratory variation, a significant fraction is apparently contributed by biologic these agents are only now being developed, and include occupancy of specific high affinity receptors that mediate the factors (35) . This aspect is discussed later under the topic of biomarkers of susceptibility and gene-environment interaction of these compounds, levels of specific mediators (growth factors, growth factor receptors, second messengers like cAMP actions.
Although chemical-specific damage to DNA by exogenous and diacylglycerol, protein kinases and the phosphorylation of specific proteins), and the expression of genes related to tumor agents remains a major mechanism in carcinogenesis, there is increasing recognition of the importance of other types of promotion, cell proliferation, apoptosis and differentiation. Examples of markers related to cell proliferation are proliferdamage to DNA by both endogenous and exogenous factors, as a driving force in carcinogenesis. The types of non-specific ating cell nuclear antigen (a nuclear antigen associated with cell division) and cyclins (proteins associated with cell-cycle DNA damage include deaminations, alkylations, base losses and oxidations. The magnitude of these effects can be influregulation) (41) . In the latter category, cyclin D1 may prove to be a very useful biomarker since it is induced by various enced by inflammatory processes and co-exposure to dietary and environmental agents. Therefore, biomarkers that assess mitogens and is frequently overexpressed in a wide variety of human cancers (42) . Recently, overexpression of cyclin D1 in the extent of these types of DNA damage will play an increasingly important role in molecular epidemiologic studies.
plasma has been associated with increased risk of breast cancer (D.L.Tang, A.Rundle, Q.W.Chen, J.Z.Zhou and P.Brandt-Rauf, An example is the development of antibodies that recognize 8-hydroxyguanosine, one of the major DNA adducts produced manuscript submitted). The fourth category of biomarkers includes those that relate by oxygen radicals (36) .
The next category of biomarkers, which reflects subsequent to inherited or acquired variations in host susceptibility. This category is a burgeoning area of research and, among all the events in the multi-step sequence of carcinogenesis, includes markers of early biologic effects resulting from exposure. Like categories of biomarkers, generates the greatest concern about ethical issues (8,43-45). The basic principles of multistage linked to increased cancer risk (63, 64 (49, 50) . Inducibility interindividual variation in only a few susceptibility factors can lead to a significant increase in population risk over that also varies between individuals, and high CYP1A1 inducibility has been correlated in a number of studies with risk of lung expected based on an assumption of uniform susceptibility, possibly by an order of magnitude or more (69) . Based on cancer (51,52). Polymorphic variations in the sequences of CYP1A1, CYP1A2, CYP1B1 and other P450s exist in the biomarker data, Hattis et al. have calculated that the variability in metabolic activity, detoxification and DNA repair among human population and specific forms have been associated with increased cancer risk in various populations (43).
95% of the US population could be as high as 85-500-fold (69) with correspondingly high variability in cancer risk. Interindividual variation in 'Phase II' detoxifying enzymes, such as GSTM 1 , can also contribute to individual susceptibility. About 40% of the population have a deletion at this locus Future directions and research needs in the field of molecuwhich has been linked to increased risk of bladder and lung lar epidemiology cancers (53-56). Another common genetic factor related to increased cancer risk is the inheritance of a homozygous There has been dramatic progress in the application of biomarkers to human studies of cancer causation. The populations recessive mutation in the N-acetyltransferase gene resulting in the inability to efficiently detoxify aromatic amines via Nstudied have included: cigarette smokers, workers in specific industries, residents exposed to air pollution, persons with acetylation. The mutation is carried by~50% of the population. It has been demonstrated that slow acetylators are at increased specific dietary patterns and cancer patients given chemotherapy. Although many of the early studies were 'transitional' in risk of bladder cancer, especially those occupationally exposed to aromatic amine bladder carcinogens (57) . Furthermore, in nature, and therefore small in scale and of limited design, they established a battery of methods that are adequately sensitive a study of blond and black tobacco smokers, slow acetylators had higher levels of 4-aminobiphenyl-hemoglobin (4-AB-Hb) for human studies and have the potential to provide valuable information on group and individual risks. Progress has been adducts in their red blood cells than fast acetylators who smoked the same type and quantity of cigarettes (58,59). In made in the development and validation of biomarkers that are directly relevant to the carcinogenic process and that can contrast to its protective effect in bladder cancer, the fast acetylator phenotype is associated with an increased risk of be used in large-scale epidemiologic studies. Study designs have become increasingly complex, with greater attention to colon cancer (60,61), demonstrating the complexity of geneenvironment interactions with respect to cancer susceptibility. the need to incorporate appropriate controls and account for potential confounders. Multiple markers, each reflecting a Moreover, combinations of metabolic polymorphisms are increasingly being linked to increased cancer risk (8).
different stage or mechanism in carcinogenesis, are frequently being assessed in the same biologic samples as well as in Acquired or inherited variations in the efficiency or fidelity of DNA repair can also influence individual susceptibility to surrogate and target tissues, to clarify the relationships between them. A number of longitudinal or nested case-control studies cancer. This principle is illustrated by the rare autosomal recessive disease xeroderma pigmentosum, in which defects have been undertaken to establish the predictive value of biomarkers. in the excision of pyrimidine dimers and other bulky DNA lesions lead to a marked increase in susceptibility to skin However, as knowledge of mechanisms in carcinogenesis has evolved, the available armamentarium of biomarkers is no cancers induced by sunlight (62). Indeed, studies of human lymphocytes have identified a~5-fold interindividual variation longer sufficient. As discussed above, the majority of the available biomarkers used in molecular epidemiologic studies in unscheduled DNA synthesis induced by UV exposure; and DNA repair deficiency (measured phenotypically) has been relate to agents that cause DNA damage and are mutagenic.
At the same time, we know that a large number of chemicals fats versus caloric excess per se to increased cancer risk. New types of biomarkers need to be developed to analyze these (hormones, various tumor promoters, pesticides, retinoids, etc.) can enhance or inhibit the carcinogenic process through indirect questions in specific human populations. For example, it is well known that calorie restriction can genotoxic or epigenetic mechanisms. They appear to act by altering gene expression, cell proliferation, differentiation and/ markedly inhibit tumor formation in mice. A variety of mechanisms have been invoked. The level of insulin-like or apoptosis (programmed cell death). Therefore, a current challenge is to develop more biomarkers for this category of growth factor-1 (IGF-1) may play a critical role since the serum level of this protein is reduced in calorically restricted agents and to incorporate them into molecular epidemiology studies.
mice and continuous infusion of IGF-1 into these mice enhances tumor formation (74) . A variety of other experimental studies For example, there is increasing evidence that in addition to mutations due to damage to DNA, the carcinogenic process implicate IGF-1 and signalling through its receptor (IGF-1r) in carcinogenesis. Futhermore, several types of human tumors, is often associated with aberrant hypermethylation of CpG islands in the promoter regions of various genes, leading to including breast, colon and lung carcinomas, overexpress either IGF-1 or IGF-1r (for review see ref. 75). High serum levels their transcriptional inactivation. These genes encode various proteins including the cell-cycle inhibitory protein p16 ink4 , the of IGF1 have been implicated in human cancer of the prostate (76) and breast (77) . It is known that diets high in fat and DNA mismatch repair protein hMLH1, and the detoxification enzyme glutathione S-transferase π (70). Since these changes high glycemic index carbohydrates can lead to a state of insulin resistance, with hyperglycemia, impaired glucose tolerance and can enhance the process of tumor progression, they might provide informative biomarkers in cell samples obtained from hyperinsulinemia. One hypothesis is that this process can enhance colon carcinogenesis because of the mitogenic effects individuals at risk of developing cancer.
Additional assays are needed to study oxygen radicals and of insulin and related factors (for review see ref. 78 ). Therefore, assays for serum levels of IGF-1, insulin and other polypeptide oxidant stress, the metabolism of nitrogen oxide and nitrites, alterations in DNA methylation, the activities of specific growth factors may provide informative biomarkers in molecular epidemiologic studies on nutrition and cancer. A related protein kinases, activation of various cytoplasmic and nuclear receptors and transcription factors, cyclins and other cell-cycle issue is whether biomarkers can be developed to better assess the putative role of exercise as a protective factor for breast control proteins, and aberrant cell proliferation, differentiation, apoptosis and angiogenesis. During the multistage process of and other cancers. Recent studies suggest that individuals who have a methylcarcinogenesis, mutations and/or epigenetic disorders in the expression of numerous genes can occur, and this can lead to deficient diet are at higher risk of colon cancer if they carry a defective polymorphic form of the enzyme methylene tetrahymarked changes in the overall circuitry of signal transduction and cell cycle control (for review see ref. 71). Recent advances drofolate reductase (79). Moreover, a decreased level of PAH-DNA adducts in the peripheral white blood cells of cigarette in genomics, microarray technology and informatics have made it possible to analyze small numbers of cells for their profiles smokers has been reported in persons with high plasma levels of α-tocopherol, but only in those individuals who lack the of expression of many different genes. As these techniques become more available they can be applied to exfoliated GSTM1 detoxifying gene, which is detected in 30-50% of the Caucasian population (80, 81) . Studies are needed also on cells and small biopsies of normal tissues, precursor lesions and tumors.
polymorphic variations in genes involved in energy metabolism or in the metabolism of lipids. As mentioned earlier, polymorphic variation in several types of genes may influence cancer susceptibility at the population Specific viruses or bacteria may be important cofactors in the causation of certain types of human cancer, acting in level. In addition to the metabolism of xenobiotics, these polymorphisms can affect the metabolism of various dietary concert with environmental chemical agents, dietary factors or hereditary susceptibility factors. Examples include hepatitis B factors, the endogenous synthesis, metabolism and action of hormones, DNA repair, immune and inflammatory processes, and C viruses in the causation of liver cancer, EpsteinBarr virus (EBV) in Burkitt's lymphoma and nasopharyngeal oxidant stress, signal transduction and cell-cycle control. Therefore, recently launched nationwide efforts to assemble and carcinoma, HPV in cervical cancer, human Herpes virus in Kaposi's sarcoma and Helicobacter pylori in gastric cancer characterize a large panel of such polymorphic genes through the Human Genome and Environmental Genome Project (82). Therefore, it is important to include biomarkers for various microorganisms in molecular epidemiologic studies on (72, 73) should provide powerful new biomarkers to the field of molecular epidemiology. Automated DNA-chip technology specific types of human cancer. A recent trend that brings together cancer researchers will greatly facilitate the large scale application of this new technology.
interested in cancer epidemiology, chemoprevention and therapy is the increasing recognition that biomarkers developed in An extremely important area for future application of the concepts and methods of molecular epidemiology is the role the field of molecular epidemiology may also be useful as early or intermediate endpoints in studies on cancer prevention of nutrition and diet in cancer. Although epidemiologic studies suggest that nutritional factors play a causative role in Ͼ30%
by identifying 'at risk' populations and then assessing the efficacy of various types of intervention. For example, in of human cancers, the precise roles of specific dietary factors are uncertain and often controversial. Current issues include:
interventions to prevent first or second malignancies, biomarkers can help identify populations or individuals at high (i) the identification of specific cancer-preventive chemicals in fruits, vegetables and various phytochemicals, including risk of cancer resulting from specific environment-gene interactions. Measures could then be taken to reduce exposure (i.e. antioxidants; (ii) the influence of genetic factors on individual cancer risk from dietary factors; (iii) the carcinogenic role of through clean-up of the workplace, modification of the diet, tighter air quality regulations, etc.), to carry out early cancer heterocyclic amines that are generated by cooking meat at high temperatures; and (iv) the contribution of specific dietary detection screening, or to initiate chemoprevention when 
